A One-year Partial Double-blinded, Randomized, Multi-center, Multi-national Study to Assess the Effects of Combination Therapy of Annual Zoledronic Acid (5 mg) and Daily Subcutaneous Teriparatide (2mcrg) on Postmenopausal Women With Severe Osteoporosis

The purpose of this study is to assess the effects of zoledronic acid administered at the same time with teriparatide compared to zoledronic acid alone and teriparatide alone on bone mineral density (BMD) gain in the lumbar spine and total hip

本研究旨在评估同时给予唑来膦酸（zoledronic acid）与特立帕肽（teriparatide），相较于单独给予唑来膦酸、单独给予特立帕肽，对腰椎与全髋部位骨密度（BMD）增益的影响。